Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
| ▸ | TRPV1 | Q8NER1 | 5/20 | 0.48 |
| ▸ | HTR1F | P30939 | 3/20 | 0.46 |
| ▸ | HTR1A | P08908 | 2/20 | 0.46 |
| ▸ | HTR1B | P28222 | 2/20 | 0.46 |
| ▸ | RORC | P51449 | 8/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | GALK1 | P51570 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | ATR | Q13535 | 1/20 | 0.42 |
| ▸ | HTR1D | P28221 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27195745 | 1.00 | CNR1 (0.51) | CNR1TRPV1HTR1FHTR1AHTR1B | |
| SCHEMBL27195727 | 0.87 | CNR1 (0.53) | CNR1TRPV1HTR1FHTR1AHTR1B | |
| Hydrochloric Acid SCHEMBL30863459 | 0.87 | CNR1 (0.57) | CNR1TRPV1HTR1FHTR1AHTR1B | |
| SCHEMBL27195735 | 0.85 | CNR1 (0.51) | CNR1TRPV1HTR1FHTR1AKDM4E | |
| SCHEMBL27195713 | 0.84 | HDAC6 (0.60) | CNR1TRPV1HTR1FKDM4EMAPT | |
| SCHEMBL30863479 | 0.76 | TRPV1 (0.50) | CNR1TRPV1KDM4EMAPT | |
| SCHEMBL27195711 | 0.76 | HDAC6 (0.60) | CNR1TRPV1HTR1F | |
| SCHEMBL27195706 | 0.76 | TRPV1 (0.58) | CNR1TRPV1 | |
| SCHEMBL27195702 | 0.75 | CNR1 (0.48) | CNR1TRPV1EPHX2 | |
| SCHEMBL30863450 | 0.75 | TRPV1 (0.57) | CNR1TRPV1KDM4EMAPTGALK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4581017-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2025-07-09 | — | — | EP | disclosed |
| WO-2024079072-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | BIODOL THERAPEUTICS (FR) | 2024-04-18 | — | — | WO | disclosed |